Want to see DE:MED full AI Analyst Report?
MED Stock Chart & Stats
€3.60
-€0.06(-2.44%)
At close: 4:00 PM EST
€3.60
-€0.06(-2.44%)
Day’s Range― - ―
52-Week Range€2.86 - €4.26
Previous CloseN/A
Volume500.00
Average Volume (3M)5.25K
Market Cap
€196.65M
Enterprise Value€483.17M
Total Cash (Recent Filing)€152.40M
Total Debt (Recent Filing)€384.07M
Price to Earnings (P/E)6.9
Beta0.21
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.96%
Share Statistics
EPS (TTM)0.60
Shares Outstanding47,500,000
10 Day Avg. Volume4,347
30 Day Avg. Volume5,253
Financial Highlights & Ratios
PEG Ratio1.78
Price to Book (P/B)0.71
Price to Sales (P/S)0.22
P/FCF Ratio3.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.78
Revenue Forecast (FY)€805.60M
Bulls Say, Bears Say
Bulls Say
Diversified Care SegmentsOperating across acute care, rehabilitation and nursing care gives MEDICLIN durable revenue diversification and exposure to multiple payer streams. This reduces single-segment risk, supports steadier utilization across cycles, and enables capacity reuse and cross-referrals for sustained demand.
Material Revenue ImprovementA 26% TTM revenue increase signals meaningful recent expansion in volumes or pricing. Sustained top-line growth supports operating leverage potential, helps rebuild margins after weakness, and creates a stronger base for reinvestment and gradual deleveraging over multiple quarters.
Healthy Operating Cash GenerationConsistent positive operating cash flow (~€94m TTM) and FCF (~€49m TTM) provide MEDICLIN with internal funding for maintenance capex, working capital and debt servicing. Durable cash generation improves financial resilience versus peers reliant on external financing.
Bears Say
Elevated LeverageA debt-to-equity around 1.46x leaves the capital structure relatively heavy, limiting strategic flexibility. High leverage increases sensitivity to funding costs and earnings swings, meaning shocks to reimbursement or volumes could materially constrain investment and require refinancing over the medium term.
Thin, Volatile ProfitabilityLow single-digit net and EBIT margins and a history of swings (including a prior loss) indicate earnings are sensitive to cost, occupancy and reimbursement variability. Sustaining margins will require consistent operational improvements and stable payer terms to absorb inflation and staffing costs.
Limited FCF Conversion And Slow DeleveragingFCF that is only ~50% of net income and negative FCF growth mean conversion is moderate. With operating cash flow modest relative to debt, the company may deleverage only gradually, constraining capacity for capex, acquisitions or accelerated balance-sheet repair without external funding.
MED FAQ
What was MEDICLIN AG’s price range in the past 12 months?
MEDICLIN AG lowest stock price was €2.86 and its highest was €4.26 in the past 12 months.
What is MEDICLIN AG’s market cap?
MEDICLIN AG’s market cap is €196.65M.
When is MEDICLIN AG’s upcoming earnings report date?
MEDICLIN AG’s upcoming earnings report date is Jul 30, 2026 which is in 7 days.
How were MEDICLIN AG’s earnings last quarter?
MEDICLIN AG released its earnings results on May 04, 2026. The company reported €0.074 earnings per share for the quarter, beating the consensus estimate of N/A by €0.074.
Is MEDICLIN AG overvalued?
According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued.
Does MEDICLIN AG pay dividends?
MEDICLIN AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.96%. See more information on MEDICLIN AG dividends here
What is MEDICLIN AG’s EPS estimate?
MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MEDICLIN AG have?
MEDICLIN AG has 47,500,000 shares outstanding.
What happened to MEDICLIN AG’s price movement after its last earnings report?
MEDICLIN AG reported an EPS of €0.074 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.725%.
Which hedge fund is a major shareholder of MEDICLIN AG?
Currently, no hedge funds are holding shares in DE:MED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MEDICLIN Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.90%
12-Months-Change
Fundamentals
Return on Equity
0.96%
Trailing 12-Months
Asset Growth
-6.83%
Trailing 12-Months
Company Description
MEDICLIN AG
Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.
Technical Analysis
RHON-KLINIKUM AG
―
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
Gesundheitswelt Chiemgau AG
―
M1 Kliniken AG
―